Recap: Oscar Health Q4 Earnings
Portfolio Pulse from Benzinga Insights
Oscar Health (NYSE:OSCR) reported Q4 earnings with an EPS of $-0.66, beating estimates by 8.33% and showing a revenue increase of $436.87 million from the previous year. The company has a history of surpassing EPS estimates, leading to a positive impact on its share price the following day.
February 07, 2024 | 9:35 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Oscar Health reported a positive Q4 earnings surprise with an EPS of $-0.66, surpassing the estimate of $-0.72 and showing significant revenue growth from the previous year.
Given Oscar Health's history of surpassing EPS estimates and the subsequent positive reaction in its share price, the Q4 earnings beat is likely to have a similar short-term positive impact on the stock. The consistent performance in beating earnings estimates and the significant year-over-year revenue growth are key factors supporting this outlook.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100